Caspers Dave 4

What Happened Dave Caspers, President, CEO and a director of Ardent Health, was granted 103,653 restricted stock units (reported as an acquisition at $0.00 per share) on July 1, 2026. The grant is an equity award (not an open‑market purchase or sale); the reported acquisition value on the Form 4 is $0 because these are RSUs that convert to shares only upon vesting.

Key Details

• Transaction date: 2026-07-01 (Form filed 2026-07-02). Transaction code: A (award/grant).
• Shares/units: 103,653 RSUs granted at $0.00 per share (award).
• Vesting: Footnote F1 — vests in three substantially equal installments on each anniversary of July 1, 2026, subject to continued service through each vesting date.
• Shares owned after transaction: Not disclosed in the provided filing details.
• Timeliness: Filing appears timely (reported period 2026-07-01, filed 2026-07-02).

Context RSU grants are a common form of executive compensation and represent the right to receive shares in the future if vesting conditions are met; they do not represent immediate purchases or sales. Because these RSUs vest over three years, any eventual stock receipt (and taxable event) will occur on each vesting date and may be subject to tax withholding or company policies. This award should be viewed as compensation-related rather than an immediate signal of insider buying or selling.